https://beta.demy-colton.com/digital-medicine-medtech-showcase-convenes-in-san-francisco-january-13-15-2020/2023-12-18T03:49:25-05:00https://beta.demy-colton.com/jpm-no-sleep-exiled-mattresses-cleared-bank-accounts-getting-deals-done-at-jpm/2023-12-18T03:55:01-05:00https://beta.demy-colton.com/personalization-prediction-and-prevention-drive-the-second-transformation-of-medicine/2023-12-18T03:56:55-05:00https://beta.demy-colton.com/drugging-the-undruggable-how-ai-does-the-almost-impossible/2023-12-18T03:58:09-05:00https://beta.demy-colton.com/alzheimers-drugs-on-verge-of-becoming-mainstream-medicine-but-early-intervention-still-is-needed/2023-12-18T03:59:38-05:00https://beta.demy-colton.com/alzheimers-is-not-a-silent-disease-if-you-are-listening/2023-12-18T04:05:16-05:00https://beta.demy-colton.com/listening-well-and-early-to-the-signs-of-alzheimers-disease/2023-12-29T03:56:07-05:00https://beta.demy-colton.com/expert-panel-points-to-central-role-of-endothelial-injury-and-lectin-pathway-activation-in-critically-ill-covid-19-patients/2023-12-18T04:42:01-05:00https://beta.demy-colton.com/lessons-from-bergamo-halting-the-complement-cascade-may-stop-covid-19-in-its-tracks/2023-12-18T04:41:52-05:00https://beta.demy-colton.com/prepping-for-covid-19s-next-wave-is-the-glass-half-full-or-half-empty/2023-12-18T04:43:27-05:00https://beta.demy-colton.com/a-fireside-chat-with-j-p-morgans-michael-gaito-head-of-healthcare-investment-banking/2023-12-18T04:45:01-05:00https://beta.demy-colton.com/new-york-city-is-not-dead-our-life-sciences-sector-is-thriving/2023-12-18T04:46:53-05:00https://beta.demy-colton.com/femtech-presents-enticing-market-opportunity/2023-12-18T04:50:35-05:00https://beta.demy-colton.com/lessons-from-biotech-entrepreneurs-pitching-your-first-in-class-innovation/2023-12-29T03:52:27-05:00https://beta.demy-colton.com/fda-deputy-commissioner-discusses-modernization-strategies-for-data-and-trials/2023-12-18T05:10:57-05:00https://beta.demy-colton.com/spacs-soar-as-fast-hassle-free-ipo-alternatives-for-biotech-companies/2023-12-18T05:12:47-05:00https://beta.demy-colton.com/bioelectric-medicine-ready-for-prime-time-as-companies-advance-therapies/2023-12-18T05:14:16-05:00https://beta.demy-colton.com/sars-cov-2-causes-heart-damage-in-20-of-people-with-mild-or-no-covid-19-symptoms/2023-12-18T05:15:47-05:00https://beta.demy-colton.com/bioscience-and-healthcare-of-the-future-overrun-by-choices-changes-and-opportunities/2023-12-18T05:17:29-05:00https://beta.demy-colton.com/top-operation-warp-speed-official-shares-lessons-learned-from-covid-19/2023-12-19T04:14:27-05:00https://beta.demy-colton.com/covid-19-to-have-long-lasting-effect-on-biotech-industry/2023-12-19T04:15:39-05:00https://beta.demy-colton.com/even-in-a-virtual-jpm-week-we-need-to-maintain-the-relationship-glue-that-keeps-the-biotech-industry-strong/2023-12-19T04:17:46-05:00https://beta.demy-colton.com/china-showcase-2021-highlights-trends-and-areas-ripe-for-investment/2023-12-19T04:19:52-05:00https://beta.demy-colton.com/jpm-can-we-take-j-p-morgan-out-of-san-francisco-were-virtually-there/2023-12-19T04:22:39-05:00https://beta.demy-colton.com/drug-prices-top-of-mind-as-pharma-leaders-consider-policies-under-biden/2023-12-19T04:24:01-05:00https://beta.demy-colton.com/until-we-meet-again-reflections-from-a-jpmorgan-health-conference-like-no-other/2024-01-30T21:35:57-05:00https://beta.demy-colton.com/cell-and-gene-therapies-shatter-prior-records-with-continued-growth-expected/2023-12-19T04:27:40-05:00https://beta.demy-colton.com/astrazeneca-manufacturing-should-take-lions-share-of-credit-for-vaccine-success/2023-12-19T04:29:36-05:00https://beta.demy-colton.com/determining-value-is-as-critical-to-commercial-success-as-clinical-data/2023-12-19T04:31:02-05:00https://beta.demy-colton.com/cervical-cancer-treatments-bubbling-in-late-stage-clinical-efforts/2024-01-30T21:35:21-05:00https://beta.demy-colton.com/sepsis-standard-of-care-fails-while-novel-meds-and-diagnostics-go-unused/2023-12-19T04:33:32-05:00https://beta.demy-colton.com/biotech-spacs-can-expect-a-good-runway-as-investors-focus-on-quality/2023-12-19T04:34:42-05:00https://beta.demy-colton.com/demy-colton-announces-biofuture-conference-to-be-held-at-cure-deerfields-vertical-innovation-campus-in-new-york-city/2024-01-30T21:34:48-05:00https://beta.demy-colton.com/translating-psychedelic-experiences-into-targeted-health-outcomes-optimism-and-concern-missing-content/2023-12-29T03:49:04-05:00https://beta.demy-colton.com/ophthalmology-companies-see-global-opportunities-for-next-gen-non-invasive-therapies/2023-12-19T04:39:00-05:00https://beta.demy-colton.com/demy-colton-announces-biofuture-speaker-lineup-and-panel-sessions-on-october-5-6-at-cure-by-deerfield-in-new-york-city/2024-01-30T21:27:24-05:00https://beta.demy-colton.com/are-digital-therapeutics-the-next-generation-of-medical-products/2023-12-19T04:43:05-05:00https://beta.demy-colton.com/biofuture-conference-2021-launch-in-new-york-city-inspires-innovation-across-life-sciences-and-digital-health/2024-01-30T21:26:29-05:00https://beta.demy-colton.com/14th-annual-biotech-showcase-to-bring-global-life-science-executives-investors-back-together-for-discovery-investing-and-collaboration/2024-01-30T21:25:06-05:00https://beta.demy-colton.com/virtual-biotech-showcase-draws-over-300-life-science-companies/2024-01-30T21:24:23-05:00https://beta.demy-colton.com/how-covid-19-has-shed-light-on-importance-of-biotech-tools-health-equity/2024-01-30T21:21:29-05:00https://beta.demy-colton.com/novel-vaccines-with-novel-targets-emerge-at-biotech-showcase/2023-12-19T04:50:08-05:00https://beta.demy-colton.com/14th-annual-biotech-showcase-brings-together-one-of-the-largest-most-informative-biotech-investment-conferences-virtually/2024-01-30T21:20:55-05:00https://beta.demy-colton.com/demy-colton-announces-launch-of-biofuture-conference/2024-01-30T21:33:21-05:00https://beta.demy-colton.com/over-550-attendees-expected-at-biofuture-conference-in-new-york-city/2024-01-30T21:22:59-05:00https://beta.demy-colton.com/tonix-pharmaceuticals-to-present-at-the-2022-biofuture-conference/2024-01-30T21:19:29-05:00https://beta.demy-colton.com/phanes-therapeutics-to-present-at-biofuture-2022/2024-01-30T21:17:13-05:00https://beta.demy-colton.com/biofuture-conference-brings-together-stakeholders-in-transformative-healthcare-summit/2024-01-30T21:32:08-05:00https://beta.demy-colton.com/15th-annual-biotech-showcase-brings-together-one-of-the-largest-most-informative-in-person-biotech-investment-conferences/2024-01-30T21:13:02-05:00https://beta.demy-colton.com/demy-colton-to-convene-more-than-700-biofuturists-shaping-whats-next-in-healthcare/2024-01-30T21:30:03-05:00https://beta.demy-colton.com/join-google-regeneron-scientific-american-ppd-thermo-fisher-and-top-tier-vcs-members-of-the-media-and-public-and-private-biotechs-exploring-the-big-questions-in-health-and-bio-at-the-biofuture/2024-01-30T21:28:43-05:00https://beta.demy-colton.com/biofuture-2023-wraps-up-after-convening-hundreds-of-high-profile-attendees-and-record-numbers-of-investors-and-media/2024-01-30T21:14:26-05:00https://beta.demy-colton.com/demy-colton-changes-the-biotech-game-with-invite-only-off-record-ceo-summits/2023-12-27T19:28:33-05:00https://beta.demy-colton.com/understanding-the-types-of-chinese-patents/2023-12-27T19:31:23-05:00https://beta.demy-colton.com/featured-on-human-proof-of-concept-podcast/2023-12-27T19:34:26-05:00https://beta.demy-colton.com/the-challenges-of-bringing-new-vaccines-to-china/2023-12-27T19:36:11-05:00https://beta.demy-colton.com/the-purposeful-biotech-ceo/2023-12-27T19:37:12-05:00https://beta.demy-colton.com/the-biotech-showcase-difference/2023-12-27T19:39:52-05:00https://beta.demy-colton.com/the-untold-story-of-biotech-and-pharma/2023-12-27T19:41:12-05:00https://beta.demy-colton.com/biotech-showcase-highlights-six-therapeutic-areas-garnering-attention-for-investment-in-2019/2023-12-27T19:43:52-05:00https://beta.demy-colton.com/biotech-showcase-celebrates-record-attendance-by-life-science-investors-ceos/2023-12-27T19:44:59-05:00https://beta.demy-colton.com/brainstorm-cell-therapeutics-halfway-through-enrolling-its-phase-3-als-study/2023-12-27T19:52:23-05:00https://beta.demy-colton.com/trendy-genes-citing-surge-in-cell-and-gene-therapy-ind-submissions-fda-previews-new-related-policies/2023-12-27T19:53:20-05:00https://beta.demy-colton.com/welcome-to-the-q4-2018-issue-of-life-sciences-international-review/2023-12-27T19:54:05-05:00https://beta.demy-colton.com/view-biotech-showcase-2020-audio-interviews/2023-12-27T20:03:29-05:00https://beta.demy-colton.com/biofuture-returns-to-new-york-city-october-28-30-with-the-launch-of-techbio-showcase/2024-09-26T03:02:32-04:00https://beta.demy-colton.com/join-regeneron-ibm-ipsen-and-venture-capitalists-at-demy-coltons-biofuture-2024/2024-09-27T11:23:14-04:00https://beta.demy-colton.com/biofuture-2024-tackles-the-industrys-critical-challenges-and-opportunities/2024-10-15T11:10:57-04:00https://beta.demy-colton.com/biofuture-2024-wraps-up-hundreds-of-high-profile-attendees-joined-record-numbers-of-investors-and-media/2024-11-22T16:49:39-05:00https://beta.demy-colton.com/xiaorong-he-on-boehringer-ingelheims-investments-in-ai-broader-applications-in-pharma/2024-12-02T14:49:26-05:00https://beta.demy-colton.com/biotech-showcase-2025-3200-attendees-and-1200-investors-set-to-convene-in-san-francisco-for-leading-biotech-investor-conference/2024-12-10T10:40:41-05:00https://beta.demy-colton.com/beefed-up-security-in-store-at-j-p-morgan-healthcare-conference/2025-01-14T12:54:25-05:00https://beta.demy-colton.com/biotech-showcase-2025-innovation-insights-for-the-year-ahead/2025-01-30T13:58:46-05:00https://beta.demy-colton.com/neurodegenerative-disease-investment-shifting-paradigms-beyond-amyloid-and-tau/2025-03-11T17:04:11-04:00https://beta.demy-colton.com/rare-disease-therapeutic-development-facing-challenges/2025-03-11T17:14:42-04:00https://beta.demy-colton.com/seven-years-after-fda-approval-have-cd19-car-t-cells-met-expectations/2025-05-08T10:38:57-04:00https://beta.demy-colton.com/biofuture-2025-returns-to-new-york-city-october-13-15/2025-09-02T12:21:42-04:00https://beta.demy-colton.com/biofuture-2025-explores-the-next-era-of-innovation-policy-and-investment-in-biopharma/2025-09-23T11:22:50-04:00https://beta.demy-colton.com/biofuture-notebook-state-of-industry-seen-as-bewildering-confusing-and-uncertain/2025-10-22T16:44:18-04:00https://beta.demy-colton.com/life-sciences-techbio-and-investment-leaders-at-demy-coltons-biofuture-2025-suggest-health-and-biotech-sectors-show-signs-of-new-life/2025-11-06T11:22:53-05:00https://beta.demy-colton.com/biotech-showcase-2026-returns-to-san-francisco-during-jpm-week-as-a-premier-destination-for-dealmakers/2025-12-09T11:35:20-05:00https://beta.demy-colton.com/during-j-p-morgan-healthcare-week-biotech-showcase-provides-private-and-micro-to-mid-cap-public-company-executives-one-stop-access-to-investors-pharma-partners-and-media/2026-01-08T17:32:31-05:00https://beta.demy-colton.com/biotech-showcase-at-18-the-other-center-of-gravity/2026-01-21T13:47:28-05:00https://beta.demy-colton.com/biotech-showcase-2026-brought-early-stage-biotech-innovation-to-the-forefront-during-jpm-healthcare-week/2026-02-09T18:28:28-05:00